文献速递临床试验与 GCP医学教育与科研方法

规划适应性平台试验的关键考量:第一部分

Key considerations for planning adaptive platform trials: part 1.
PubMed 文献 · J Clin Epidemiol · 2026-03-06

适应性平台试验(APTs)是在核心方案下持续加入干预措施的复杂随机对照试验,具有灵活性、效率和成本效益优势,但规划复杂且指导有限。本文基于规划与启动APTs的经验,提供第一部分5项总体考量:利益相关者参与、人群与场景、干预与对照、临床结局及适应性调整。

要点

  • APTs规划需系统考虑利益相关者参与、人群与场景、干预与对照、临床结局和适应性调整。
  • APTs相比传统独立RCT具有灵活性、效率和成本效益优势。
  • 目前APTs规划指导有限,本文基于实践经验提供关键考量。

核心结论

  • 本文提供的APTs规划关键考量指导将有助于考虑或规划APTs的研究者。

研究设计与样本

  • 本文为两部分系列中的第一部分,基于作者规划与启动APTs的自身经验,提供临床场景下APTs规划的叙述性概述。

主要发现

  • 第一部分涵盖5项总体考量:利益相关者参与、人群与场景、干预与比较、临床结局以及适应性调整。

临床怎么用

  • 研究者在考虑或规划APTs时,可参考本文提出的5项总体考量进行系统规划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: There is an increased interest in adaptive platform trials (APTs), that is, complex randomized clinical trials (RCTs) focusing on a population or a setting, conducted according to a core protocol, with continuous addition of interventions during trial conduct. APTs may run perpetually, assessing many different interventions. APTs come with benefits regarding increased flexibility, efficiency, and cost-effectiveness compared to conventional, stand-alone RCTs. However, planning APTs is complex, and limited guidance is available. METHODS: In this two-part series, we provide a narrative overview of key considerations for the planning of APTs in a clinical setting based on our own experiences planning and initiation APTs. RESULTS: This first part covers the following 5 overall considerations: stakeholder involvement, population and setting, interventions and comparisons, clinical outcomes, and adaptations. The second part covers 7 additional overall considerations: statistics and performance, other design features, data infrastructure, operations and organization, funding, dissemination, and implementation. CONCLUSION: The provided guidance on key considerations when planning APTs will aid researchers considering or planning APTs.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Granholm A, Møller MH, Rosso A, et al. Key considerations for planning adaptive platform trials: part 1. J Clin Epidemiol. 2026. PMID: 41796755. doi:10.1016/j.jclinepi.2026.112212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。